Your browser is no longer supported. Please, upgrade your browser.
Settings
RDUS Radius Health, Inc. daily Stock Chart
RDUS [NASD]
Radius Health, Inc.
Index- P/E- EPS (ttm)-5.79 Insider Own0.26% Shs Outstand46.80M Perf Week-6.86%
Market Cap819.47M Forward P/E- EPS next Y-4.30 Insider Trans- Shs Float45.36M Perf Month-12.41%
Income-259.30M PEG- EPS next Q-1.26 Inst Own- Short Float19.22% Perf Quarter-44.08%
Sales58.30M P/S14.06 EPS this Y-36.70% Inst Trans-5.16% Short Ratio9.71 Perf Half Y-48.45%
Book/sh3.01 P/B5.82 EPS next Y21.00% ROA-60.00% Target Price40.67 Perf Year-48.06%
Cash/sh4.94 P/C3.55 EPS next 5Y31.30% ROE-117.90% 52W Range16.71 - 41.16 Perf YTD-44.89%
Dividend- P/FCF- EPS past 5Y-12.60% ROI-61.00% 52W High-55.39% Beta0.94
Dividend %- Quick Ratio5.30 Sales past 5Y- Gross Margin92.60% 52W Low9.87% ATR0.90
Employees463 Current Ratio5.40 Sales Q/Q2209.10% Oper. Margin- RSI (14)32.84 Volatility4.48% 4.64%
OptionableYes Debt/Eq1.26 EPS Q/Q3.80% Profit Margin- Rel Volume1.34 Prev Close17.51
ShortableYes LT Debt/Eq1.26 EarningsAug 07 BMO Payout- Avg Volume897.36K Price18.36
Recom2.30 SMA20-6.14% SMA50-19.44% SMA200-39.82% Volume388,626 Change4.85%
Mar-29-18Initiated Leerink Partners Outperform $53
Jan-29-18Initiated Morgan Stanley Overweight $57
Dec-06-17Initiated Citigroup Neutral $30
Oct-06-17Resumed Goldman Neutral
Mar-24-17Reiterated H.C. Wainwright Buy $71 → $66
Sep-21-16Reiterated H.C. Wainwright Buy $55 → $71
Aug-04-16Downgrade Maxim Group Hold → Sell $24
May-23-16Initiated H.C. Wainwright Buy $55
Mar-30-16Initiated Goldman Neutral
Feb-24-16Downgrade Jefferies Buy → Hold
Oct-02-15Initiated JP Morgan Overweight $88
Sep-24-15Reiterated Canaccord Genuity Buy $70 → $85
Aug-14-15Initiated Deutsche Bank Buy $90
Jun-22-15Downgrade Maxim Group Buy → Hold
Jun-18-15Reiterated Cantor Fitzgerald Buy $58 → $71
Apr-24-15Initiated Cowen Buy $50
Sep-11-18 09:15AM  Radius Health to Present at the Morgan Stanley 16th Annual Global Health Care Conference GlobeNewswire
Sep-06-18 04:15PM  Radius Health Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire
11:29AM  Why Is Radius Health (RDUS) Down 11.8% Since Last Earnings Report? Zacks
Sep-04-18 09:15AM  Radius Health Appoints Dr. Charles Morris as Chief Medical Officer GlobeNewswire
08:00AM  BioXcel Therapeutics Appoints Dr. David C. Hanley as Vice President and Head of Global Pharmaceutical Development and Operations GlobeNewswire
Aug-21-18 01:45AM  Edited Transcript of RDUS earnings conference call or presentation 7-Aug-18 12:00pm GMT Thomson Reuters StreetEvents +5.26%
Aug-07-18 11:20AM  Radius (RDUS) Q2 Loss Narrower Than Expected, Tymlos Sales Up Zacks
09:05AM  Radius Health (RDUS) Reports Q2 Loss, Tops Revenue Estimates Zacks
07:57AM  Radius Health: 2Q Earnings Snapshot Associated Press
07:45AM  Radius Health Reports Second Quarter 2018 Financial and Operating Results and Provides Business Update GlobeNewswire
06:00AM  Radius Health Inc to Host Earnings Call ACCESSWIRE
Aug-02-18 09:43AM  Is a Beat in Store for Radius Health (RDUS) in Q2 Earnings? Zacks
Aug-01-18 07:30AM  New Research Coverage Highlights Ladder Capital, Gibraltar Industries, Norwegian Cruise Line, Wolverine World Wide, Catalyst Pharmaceuticals, and Radius Health Consolidated Revenues, Company Growth, and Expectations for 2018 GlobeNewswire
Jul-31-18 07:00AM  Free Technical Reports on Sarepta Therapeutics and Three Additional Biotech Equities ACCESSWIRE
Jul-24-18 04:15PM  Radius Health Provides Update on Appeal of CHMP Opinion for Abaloparatide-SC GlobeNewswire
Jul-23-18 04:44PM  Radius Health to Announce Second Quarter 2018 Financial Results, Host Conference Call and Live Webcast on August 7, 2018 GlobeNewswire
Jul-16-18 07:28PM  Radius Health Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire
08:00AM  Radius Health Strengthens Senior Management Team with Appointment of Chhaya Shah as Senior Vice President of Technical Operations GlobeNewswire
Jun-28-18 07:35AM  Complimentary Technical Snapshots on Puma Biotech and Three More Biotech Stocks ACCESSWIRE
Jun-11-18 04:33AM  Why Is Radius Health (RDUS) Down 9.7% Since its Last Earnings Report? Zacks
Jun-07-18 08:30AM  Radius Health to Present at the Goldman Sachs 39th Annual Global Healthcare Conference GlobeNewswire
Jun-05-18 08:30AM  Radius to Host Investor Day on June 8, 2018 GlobeNewswire
May-31-18 10:03AM  Edited Transcript of RDUS earnings conference call or presentation 10-May-18 12:00pm GMT Thomson Reuters StreetEvents
May-17-18 12:02PM  Value-Adding Growth Stocks To Buy Now Simply Wall St.
May-11-18 08:09PM  Radius Health to Present at the Bank of America Merrill Lynch 2018 Annual Healthcare Conference GlobeNewswire
09:52AM  Radius Health (RDUS) Incurs Narrower-Than-Expected Q1 Loss Zacks
May-10-18 07:51AM  Radius Health: 1Q Earnings Snapshot Associated Press
07:30AM  Radius Health Reports First Quarter 2018 Financial and Operating Results and Provides Business Update GlobeNewswire
May-07-18 09:28AM  What's in Store for Radius Health (RDUS) in Q1 Earnings? Zacks
Apr-24-18 08:00AM  Radius Health to Announce First Quarter 2018 Financial Results, Host Conference Call and Live Webcast on May 10, 2018 GlobeNewswire
Apr-20-18 08:10AM  Report: Developing Opportunities within Clean Energy Fuels, Catalyst Pharmaceuticals, Qorvo, Brunswick, DCT Industrial Trust, and Radius Health Future Expectations, Projections Moving into 2018 GlobeNewswire
Apr-15-18 06:05PM  Insider Buys Of The Week: Intercept Pharmaceuticals, Macy's And More Benzinga
Apr-02-18 04:42AM  Radius Health (RDUS) Down 4.3% Since Earnings Report: Can It Rebound? Zacks
Mar-30-18 02:32PM  Radius Health Initiates Phase 3 Clinical Trial of Abaloparatide Injection for the Treatment of Male Osteoporosis GlobeNewswire
Mar-23-18 09:46AM  Radius Health Down on Negative CHMP Opinion for Lead Drug Zacks
Mar-22-18 01:44PM  Walthams Radius Health says osteoporosis drug rejected in Europe American City Business Journals
09:00AM  Radius Health Provides Update on CHMP Opinion for Abaloparatide-SC GlobeNewswire
Mar-19-18 09:52AM  Radius Health Announces Positive Data on Lead Drug Tymlos Zacks
Mar-17-18 12:30PM  Radius Health Presents Positive Data for the ACTIVExtend BMD Responder Analysis for TYMLOS (abaloparatide) Injection at ENDO 2018 Annual Meeting GlobeNewswire
Mar-16-18 12:02PM  March Top Growth Stocks To Invest In Simply Wall St.
Mar-12-18 04:30PM  Radius Health to Present at ENDO 2018 Including Results of the ACTIVExtend BMD Responder Analysis for TYMLOS (abaloparatide) Injection GlobeNewswire
Mar-08-18 04:10AM  Edited Transcript of RDUS earnings conference call or presentation 1-Mar-18 9:30pm GMT Thomson Reuters StreetEvents
Mar-06-18 08:01AM  Radius Health to Present at the Cowen 38th Annual Health Care Conference GlobeNewswire
Mar-02-18 01:41PM  Here's Why Radius Health Dropped as Much as 14.7% Today Motley Fool -12.32%
11:10AM  Radius (RDUS) Q4 Loss Wider Than Expected on Higher Expenses Zacks
Mar-01-18 05:13PM  Radius Health reports 4Q loss Associated Press
04:01PM  Radius Health Reports Fourth Quarter and Full Year 2017 Financial and Operating Results and Provides Business Update GlobeNewswire
12:30PM  Radius Health Inc to Host Earnings Call ACCESSWIRE
Feb-26-18 09:05AM  Radius Health (RDUS) to Disappoint Investors in Q4 Earnings? Zacks
Feb-14-18 08:00AM  Radius Health to Present at 2018 RBC Capital Markets Global Healthcare Conference GlobeNewswire
08:00AM  Radius Health to Announce Fourth Quarter and Full Year 2017 Financial Results, Host Conference Call and Live Webcast on March 1, 2018 GlobeNewswire
07:45AM  Analysis: Positioning to Benefit within First Data, Target, Kellogg, Builders FirstSource, HD Supply, and Radius Health Research Highlights Growth, Revenue, and Consolidated Results GlobeNewswire
Feb-13-18 11:02AM  Top Growth Stocks To Buy Today Simply Wall St.
Feb-08-18 08:00AM  Radius Health to Present at Leerink Partners 7th Annual Global Healthcare Conference GlobeNewswire -7.43%
Jan-29-18 11:50AM  Analyst: Radius Health Could Advance 50% With Osteoporosis Treatment, Breast Cancer Pipeline Benzinga
Jan-26-18 07:34AM  Taking Stock of Radius Healths Financial Performance Market Realist
Jan-25-18 03:15PM  Taking Stock of Radius Healths Licensing Agreements Market Realist
01:45PM  A Strong Pipeline of Drugs Bodes Well for Radius Health Market Realist
12:13PM  Analysts Ratings for Radius Health and Its Peers in January Market Realist
Jan-12-18 12:40PM  Biotech Stocks Near Massive Breakout Investopedia
Jan-05-18 09:07AM  Radius Health to Present at the 36th Annual J.P. Morgan Healthcare Conference GlobeNewswire
Jan-03-18 11:02AM  January Top Growth Stocks Simply Wall St.
Jan-02-18 08:05AM  See what the IHS Markit Score report has to say about Radius Health Inc. Markit
08:05AM  Radius Health Welcomes Elhan Webb as Head of Investor Relations and External Communications GlobeNewswire
Dec-18-17 05:45PM  Radius Health to Get Third Day-180 List of Outstanding Issues Zacks
07:10AM  Wired News Radius Health Expects CHMP to Issue Third Day-180 List of Outstanding Issues in Its Regulatory Review of Abaloparatide-SC ACCESSWIRE
Dec-15-17 07:31AM  Radius Health Announces that the Committee for Medicinal Products for Human Use (CHMP) Will Issue a Third Day-180 List of Outstanding Issues in its Regulatory Review of Abaloparatide-SC, a Bone Building Agent for the Treatment of Osteoporosis in Postmenopausal Women at Increased Risk of Fracture GlobeNewswire
Dec-13-17 02:43PM  Radius Health, Inc. Value Analysis (NASDAQ:RDUS) : December 13, 2017 Capital Cube
Dec-12-17 08:07AM  Radius Health, Inc. breached its 50 day moving average in a Bearish Manner : RDUS-US : December 12, 2017 Capital Cube -5.16%
Dec-11-17 01:30PM  Fractured Truth Campaign Wins Bronze Pearl Award for Content Marketing Excellence in the Healthcare/Pharmaceutical Industry GlobeNewswire
Dec-08-17 05:03PM  What Happened in the Stock Market Today Motley Fool +15.29%
12:24PM  Here's Why Radius Health Is Rising Today Motley Fool
11:10AM  Radius Health Breast Cancer Trial Continues to Show Progress 24/7 Wall St.
08:04AM  See what the IHS Markit Score report has to say about Radius Health Inc. Markit
Dec-07-17 06:30PM  Radius Investigational Drug Elacestrant (RAD1901) Continues to Show Promise in Advanced ER+ / HER2- Breast Cancer at the 2017 San Antonio Breast Cancer Symposium GlobeNewswire
Dec-04-17 09:05AM  Radius Health Announces Five Presentations on elacestrant (RAD1901) at the San Antonio Breast Cancer Symposium (SABCS) GlobeNewswire
Nov-30-17 08:04AM  See what the IHS Markit Score report has to say about Radius Health Inc. Markit
08:00AM  New Research: Key Drivers of Growth for First Data, Target, Kellogg, Builders FirstSource, HD Supply, and Radius Health Factors of Influence, Major Initiatives and Sustained Production GlobeNewswire
Nov-28-17 04:27PM  Steven Cohen Boosts Stake in Radius Health GuruFocus.com +5.00%
Nov-27-17 04:35PM  Radius Health Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire
04:05PM  Radius Health Announces Commercial Leadership Changes with Appointment of Joseph Kelly as Senior Vice President of Sales and Marketing, and Promotion of Amanda Mott to Senior Vice President of Market Access GlobeNewswire
08:04AM  See what the IHS Markit Score report has to say about Radius Health Inc. Markit
Nov-21-17 08:06AM  See what the IHS Markit Score report has to say about Radius Health Inc. Markit
Nov-20-17 08:05AM  See what the IHS Markit Score report has to say about Radius Health Inc. Markit
Nov-15-17 08:04AM  See what the IHS Markit Score report has to say about Radius Health Inc. Markit
Nov-10-17 08:12AM  See what the IHS Markit Score report has to say about Radius Health Inc. Markit
07:30AM  Corporate News Blog - OncoSec Medical Reports Positive Updated Follow-Up Data from Phase-2 Trial of ImmunoPulse IL-12 in Combination with Pembrolizumab ACCESSWIRE
Nov-05-17 02:42PM  Edited Transcript of RDUS earnings conference call or presentation 2-Nov-17 8:30pm GMT Thomson Reuters StreetEvents
Nov-03-17 09:21AM  Radius Health (RDUS) Earnings Miss in Q3, Tymlos in Focus Zacks
Nov-02-17 05:30PM  Radius Health reports 3Q loss Associated Press
04:01PM  Radius Health Reports Third Quarter 2017 Financial and Operating Results and Provides Business Update GlobeNewswire
11:50AM  Radius Health Inc to Host Earnings Call ACCESSWIRE
Oct-27-17 10:02AM  Will Radius Health (RDUS) Disappoint This Earnings Season? Zacks +6.59%
Oct-18-17 09:00AM  Radius Health Receives FDA Fast Track Designation for Elacestrant (RAD1901) GlobeNewswire
Oct-13-17 11:43AM  Radius Health, Inc. Value Analysis (NASDAQ:RDUS) : October 13, 2017 Capital Cube
08:00AM  Radius Health to Present First Health Economics Data on TYMLOS (abaloparatide) Injection at the Academy of Managed Care Pharmacy Nexus 2017 GlobeNewswire
Oct-12-17 08:25AM  Radius Health, Inc. breached its 50 day moving average in a Bearish Manner : RDUS-US : October 12, 2017 Capital Cube
Oct-09-17 09:00AM  Radius Health to Announce Third Quarter 2017 Financial Results, Host Conference Call and Live Webcast on November 2, 2017 GlobeNewswire
08:04AM  See what the IHS Markit Score report has to say about Radius Health Inc. Markit
Oct-02-17 09:50AM  Radius (RDUS) Enrols First Patient in Breast Cancer Study Zacks
Radius Health, Inc., a biopharmaceutical company, develops and commercializes endocrine therapeutics in the areas of osteoporosis and oncology. The company markets TYMLOS for the treatment of postmenopausal women with osteoporosis. It is also developing abaloparatide transdermal patch, a short-wear-time patch formulation of abaloparatide that is in Phase III clinical trial to treat postmenopausal women with osteoporosis; RAD1901, a selective estrogen receptor down-regulator/degrader, which is in Phase I clinical trial for the treatment of metastatic breast cancer; and RAD140, a non-steroidal selective androgen receptor modulator that is in Phase I clinical trial to treat breast cancer. The company has collaborations and license agreements with 3M; Ipsen Pharma SAS; Eisai Co. Ltd.; Duke University; and Teijin Limited, as well as research and development agreements with Nordic Bioscience Clinical Development VII A/S. Radius Health, Inc. was founded in 2003 and is headquartered in Waltham, Massachusetts.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
BIOTECH GROWTH N V10% OwnerAug 20Buy19.6560,0001,178,8086,590,276Aug 22 11:08 AM
BIOTECH GROWTH N V10% OwnerAug 15Buy20.7869,3631,441,5306,530,276Aug 16 03:18 PM
BIOTECH GROWTH N V10% OwnerAug 14Buy20.87100,0002,086,8806,460,913Aug 16 03:18 PM
BIOTECH GROWTH N V10% OwnerAug 08Buy22.7360,0001,363,8846,360,913Aug 10 03:04 PM
BIOTECH GROWTH N V10% OwnerJul 27Buy24.8150,0001,240,6056,300,913Jul 30 05:23 PM
BIOTECH GROWTH N V10% OwnerJul 25Buy27.2850,0001,363,8056,250,913Jul 26 02:56 PM
BIOTECH GROWTH N V10% OwnerJun 11Buy27.3650,0001,367,8356,200,913Jun 13 03:29 PM
BIOTECH GROWTH N V10% OwnerMay 23Buy28.9140,0001,156,3206,150,913May 24 02:29 PM
BIOTECH GROWTH N V10% OwnerMay 21Buy29.2760,0001,756,3806,110,913May 23 02:42 PM
BIOTECH GROWTH N V10% OwnerApr 19Buy33.8040,0001,351,9366,050,913Apr 23 01:28 PM
BIOTECH GROWTH N V10% OwnerApr 05Buy36.5850,0001,828,8455,903,799Apr 09 01:19 PM
BIOTECH GROWTH N V10% OwnerMar 02Buy32.5280,0002,601,4485,853,799Mar 06 04:23 PM
BIOTECH GROWTH N V10% OwnerFeb 09Buy34.3875,0002,578,7635,773,799Feb 12 04:54 PM
BIOTECH GROWTH N V10% OwnerNov 14Buy26.2550,0001,312,3905,698,799Nov 16 12:16 PM
Hatzis-Schoch BrentSr. VP, General CounselNov 10Buy28.091,77849,9432,278Nov 13 07:26 AM
Hoiland JesperPresident and CEONov 07Buy29.046,800197,45012,900Nov 07 05:14 PM
BIOTECH GROWTH N V10% OwnerNov 03Buy29.1550,0001,457,5755,648,799Nov 07 12:44 PM
BIOTECH GROWTH N V10% OwnerOct 26Buy30.9550,0001,547,5505,598,799Oct 27 03:39 PM
BIOTECH GROWTH N V10% OwnerOct 25Buy32.8550,0001,642,4155,548,799Oct 26 06:30 PM